Publication | Closed Access

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Treatment And PreventionMedicineAntiviral Drug DevelopmentClinical TrialsAntiviral TherapyVirologyPharmacotherapyHiv-1 InfectionAntiviral DrugHivPharmacologyTenofovir Disoproxil FumaratePhase 3